Current Screening Thresholds May Miss Half of Patients with Primary Aldosterone, a Leading Cause of Severe High Blood Pressure, Finds Study in Hypertension
Go back to Current Screening Thresholds May Miss Half of Patients with Primary Aldosterone, a Leading Cause of Severe High Blood Pressure, Finds Study in Hypertension| Quest Diagnostics (NYSE: DGX) | Delayed: 238.93 +1.81 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $237.12 | 52 Week High | $86.85 | |||
| Open | $235.34 | 52 Week Low | $59.66 | |||
| Day High | $240.56 | P/E | 45.00 | |||
| Day Low | $223.50 | EPS | $5.31 | |||
| Volume | 1,205,120 | |||||



